Monthly Archives: November 2004



Contracts Keep Drug Research Findings Concealed – NY Times Mon, 29 Nov 2004 I. A front page article in the New York Times focuses on academia’s role (culpability) in keeping mum about the unpublished antidepressant clinical trial results. The unnamed focus of the article is the industry-supported American College of […]

Contracts Keep Drug Research Findings Concealed – NY Times




FDA Chief Counsel, Daniel Troy, Resigned Wed, 17 Nov 2004 FDA’s chief counsel, Daniel Troy, has resigned! This is good news for consumers. Troy was the symbol of what is rotten at the FDA: the pharmaceutical industry’s influence has ensured that business interests take precedence over public safety. Industry-influenced advisory […]

FDA Chief Counsel, Daniel Troy, Resigned


Texas Foster Care Investigation – Children as young as 3 are drugged with antipsychotics Sat, 13 Nov 2004 The Dallas Morning News reports that Texas comptroller, Carole Keeton Strayhorn, who hade conducted an investigation of the foster care system, concluded that up to $4 million a year might be wasted […]

Texas Foster Care Investigation – Children as young as 3 ...


The Washington Post reports (below) that the Environmental Protection Agency (EPA) announced plans to enroll 60 young children in Duval County, Florida - infants to age 3 - exposing them to pesticides to study how the children absorb poisonous chemicals!

In this experiment children will literally be relegated to the status of human guinea pigs. This experimental abuse of children demonstrates what the chemical / pharmaceutical industry buys when it "contributes" funds to government agencies, public officials, scientists and academic institutions.

US Gov Pesticide Exposure Experiments: Target Children–$970 per child – ...



FDA Protects Pfizer: Removes Advisory Panelist for Citing Evidence Bextra Similar to Vioxx – WSJ Fri, 12 Nov 2004 Even as the Vioxx casualties are still being counted, even as FDA’s conduct is under Congressional investigation, the FDA office of new drugs has taken action to obstruct evidence-based safety evaluation […]

FDA Protects Pfizer: Removes Advisory Panelist for Citing Evidence Bextra ...


Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086   New York, NY 10023     www.ahrp.org   November 1, 2004 Thomas W. Abrams Director Office […]

Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk ...